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 Technologies for introducing molecules into living cells are vital for probing the physical 
properties and biochemical interactions that govern the cell’s behavior.  Here we report the 
development of a nanoscale cell injection system—termed the nanoinjector—that uses 
carbon nanotubes to deliver cargo into cells.  A single muti-walled carbon nanotube 
attached to an atomic force microscope tip was functionalized with cargo via a disulfide-
based linker.  Penetration of cell membranes with this “nanoneedle”, followed by reductive 
cleavage of the disulfide bonds within the cell’s interior, resulted in the release of cargo 
inside the cells.  The capability of the nanoinjector was demonstrated by injection of 
protein-coated quantum dots into live human cells.  Single-particle tracking was employed 
to characterize the diffusion dynamics of injected quantum dots in the cytosol.  This new 
technique causes no discernible membrane or cell damage, and can deliver a discrete 
number of molecules to the cell’s interior without the requirement of a carrier solvent. 
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 Technologies for introducing exogenous materials into cells play a central role in 
experimental cell biology.  The major challenge is to overcome the barrier imposed by the 
plasma membrane.  This has been accomplished in a variety of ways, such as permeabilization of 
the membrane with lipids, electric currents, or pore-forming toxins, and physical penetration 
with a micropipette (i.e., microinjection) or microprojectile (1).  Each method has its advantages 
and disadvantages, but one common liability is physical damage to the cell membrane.  
 To overcome this problem, we sought to develop an alternative method of intracellular 
delivery that combines the microinjection concept with emerging tools from nanotechnology.  
We envisioned a “nanoinjector” that would penetrate cell membranes with minimal perturbation, 
delivering cargo to the cell’s interior with high spatial resolution (at the nanometer scale).  The 
proposed technology comprised three essential components: a needle with nanoscale diameter, a 
manipulator with nanoscale resolution, and controllable loading and releasing of cargo.  Here we 
report the construction and successful operation of a cell nanoinjector in which a single multi-
walled carbon nanotube (MWNT) attached to an atomic force microscope (AFM) tip served as 
the “nanoneedle” and an AFM integrated with an inverted fluorescence microscope served as the 
nanomanipulator (Fig. 1).   
 
Results and discussion: 
 With needle-like geometry, large Young’s modulus and high tensile strength (2, 3), 
carbon nanotubes (CNTs) are ideal nanoscale needles for this purpose.  Their diameters can be 
selected from a range of 1-20 nm, a scale that allows physical penetration of a cell’s membrane 
without significant disruption of the cell’s macrostructure.  Indeed, such a piercing, which is on 
the scale of a single protein’s diameter, should readily heal by lipid diffusion without 
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perturbation of the cytoskeleton (4).  Already, CNTs have demonstrated utility as cell 
transfection reagents and membrane penetrating delivery vehicles (5-8).   
 The nanomanipulation system was based on a commercially available AFM (MFP-3D-
BIOTM, Asylum Research, Santa Barbara, CA) that integrates an inverted fluorescence 
microscope (Nikon Eclipse TE2000-U).  The AFM platform was ideal for this application, as it 
offers control of nanoneedle displacement at nanometer scale resolution and the ability to apply 
and monitor forces on the cell membrane.  Thus, the AFM enabled precise positioning of the 
nanoneedle and high sensitivity monitoring of the membrane-piercing event.   
 The MWNT-AFM tips used in this work were fabricated as described previously (9).  In 
brief, an individual MWNT of 10-20 nm in diameter was retrieved from a metal foil by the AFM 
tip using a nanomanipulator inside a scanning electron microscope (SEM).  The MWNT was 
then cut to the desired length (0.5-1.5 μm) using an electron beam or electrical current.  SEM 
and transmission electron microscopy (TEM) images of one representative MWNT-AFM tip are 
shown in Figures 2A and B, respectively. 
 For the controlled loading and release of cargo, we aimed to design a system that would 
obviate the need for a carrier solvent and, accordingly, the addition of excess volume to the cell’s 
cytosol during the injection process.  Toward this end, we exploited established chemical 
methods for CNT surface modification (10) and the intrinsic difference in redox potential 
between the intracellular and extracellular environments (11).  Compound 1 (Fig. 3) fulfilled the 
functions of cargo loading and release as follows.  Its pyrene moiety binds strongly to CNT 
surfaces via π-π stacking (12).  Compound 1 is also endowed with a biotin moiety, separated 
from the pyrene group via a disulfide bond.  In the relatively oxidizing environment of the cell’s 
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exterior, the disulfide is stable.  However, once exposed to the reducing environment of the 
cytosol, the disulfide is cleaved, liberating attached cargo. 
 To demonstrate the function of the nanoinjector, we sought to deliver quantum dots to the 
cell’s cytosol without concomitant membrane and cell damage, effects that are hard to avoid with 
conventional delivery technologies (1).  Quantum dots have emerged as powerful optical probes 
for single particle and single molecule studies in cellular systems (13).  Their bright fluorescence 
and resistance to photobleaching have enabled single-particle tracking of membrane proteins on 
the cell surface (14) and vesicles within cells (15).  Without a delivery vehicle, quantum dots 
cannot access the cell’s cytosol and nuclei.  Accordingly, processes therein have been refractory 
to study using quantum dot technology. 
 We coated the MWNT-AFM tip with compound 1 by co-incubation in methanol.  The tip 
was then loaded with streptavidin-coated quantum dots (QDot® Streptavidin, Invitrogen) via 
non-covalent complexation of streptavidin with biotin in borate buffer (Fig. 3A).  The loaded 
MWNT-AFM tips were characterized by TEM.  As shown in Fig. 2C, multiple QDot® 
Streptavidin conjugates were successfully loaded onto a single MWNT functionalized with 
compound 1 (up to several hundred per 1-μM tip).  In a control experiment, MWNT-AFM tips 
were incubated directly with QDot® Streptavidin without prior coating with compound 1.  In this 
case, no QDot® Streptavidin conjugates were observed on the MWNT surface (see Fig. 5, which 
is published as supporting information on the PNAS web site).   
 The nanoinjection experiments were then carried out using cultured HeLa cells, a human 
cervical epithelial cancer cell line.  A target cell within the field of the optical microscope was 
identified, as indicated by the arrow in Figure 4B.  The cantilever was then positioned on top of 
the target cell and the scan size was set to 0 nm.  The deflection of the cantilever was measured 
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with a photodiode to monitor the displacement of the nanoneedle as the MWNT-AFM tip 
approached the cell surface.  After the MWNT came into contact with the cell, the cantilever was 
further lowered so that the MWNT nanoneedle penetrated the membrane and reductive cleavage 
of disufide bonds allowed the release of QDot® Streptavidin conjugates within the cell.  
Following injection, the cantilever was retracted and the cell was imaged by fluorescence 
microscopy.   
 As shown in Fig. 4, fluorescence intensity inside the target cell indicated the release of 
quantum dots.  QDot® Streptavidin conjugates were never observed in neighboring cells.  We 
confirmed that the released quantum dots were within the cell’s interior by video microscopy 
analysis.  Their mobility was limited to the confines of the cell, where they exhibited slow 
diffusion and eventual immobilization, perhaps due to interactions with organelle membranes or 
cytoskeletal fibers (see Video 1, which is published as supporting information on the PNAS web 
site).  Based on fluorescence intensity calibration experiments using free quantum dots in 
solution, and the sensitivity of our fluorescence microscope, we estimate that the fluorescence 
intensity in Fig. 4 represents small clusters of quantum dots with a diameter of 50-100 nm (i.e., 
5-50 quantum dots depending on their arrangement). 
 To rule out the possibility that release of the QDot® Streptavidin conjugates occurred by 
desorption of the pyrene moiety from the MWNT surface rather than disulfide cleavage, we 
loaded cargo onto the MWNTs using control compound 2 (Fig. 3B).  This linker possesses 
pyrene and biotin moieties, but replaces the disulfide bond with a polyethylene glycol (PEG) 
spacer separating the MWNT and streptavidin binding elements.  We functionalized MWNT-
AFM tips with 2 and then loaded QDot® Streptavidin conjugates onto the nanoneedle.  The 
modified MWNT-AFM tips were analyzed by TEM and were similar to MWNT-AFM tips 
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bearing the disulfide-bound conjugates (see Fig. 6, which is published as supporting information 
on the PNAS web site).  Similar nanoinjection experiments were carried out using HeLa cells but 
in this case no QDot® Streptavidin conjugates were released (with >5 different MWNT-AFM 
tips in >10 injection experiments) (see Fig. 7, which is published as supporting information on 
the PNAS web site).  These results have two important implications.  First, the release 
mechanism is dependent on disulfide bond cleavage and is therefore not simply due to desorption 
of the pyrene moiety from the MWNT surface.  Second, the requirement of disulfide cleavage 
confirms that cargo release occurred within the reducing environment of the cytosol. 
 A limitation of many intracellular delivery technologies is the harmful effects they exert 
on membranes and cells.  Therefore, we probed the effects of nanoinjection on membrane 
integrity and cell viability using three assays: (i) the trypan blue exclusion assay (16), (ii) the 
Calcein AM assay (17), and (iii) the Annexin V-FITC/propidium iodide (PI) assay for apoptosis 
(18) (experimental details are in the Supporting Information).  In the trypan blue assay, the dye 
was added immediately after cell nanoinjection and the cells were monitored for10 hours 
thereafter.  No trypan blue inclusion or reduction in cell viability was observed during this time 
period (see Table 1, which is published as supporting information on the PNAS web site).  In the 
Calcein AM assay, the cells were loaded with the fluorescent dye immiately prior to 
nanoinjection.  Similar to the previous results, we saw no evidence of compromised membrane 
integrity for up to 10 hours (see Fig. 8, which is published as supporting information on the 
PNAS web site).  Finally, nanoinjected cells showed no detectable staining with Annexin V-
FITC or PI up to 10 hours after the event (see Fig. 9, which is published as supporting 
information on the PNAS web site).  Thus, nanoinjection does not appear to induce apoptotic 
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pathways in the cells.  Notably, the biocompatibility of nanoinjection should allow for 
exploration of a broad range of release chemistries that occur over extended time periods. 
 The ability to deliver quantum dots to the cell’s cytoplasm provides a platform for 
numerous studies of intracellular processes.  As an example, we used the single-particle tracking 
technique (14, 15, 19) to characterize the diffusion dynamics of injected quantum dots in the 
cytosol, which has been previously studied using methods that can harm cells (20).  After 
nanoinjection, the diffusion dynamics of cytosolic quantum dots were characterized by analyzing 
the mean square distance (∆r2) and traveling time (∆t) for an injected quantum dot cluster (see 
Fig. 10, which is published as supporting information on the PNAS web site).  The slope of the 
best-fit line afforded a diffusion coefficient of 0.3 μm2/sec.  This value is approximately 10-fold 
lower than diffusion coefficients measured in pure water, which is consistent with previous 
measurements (20).  A major advantage of the biocompatible nanoinjection technology is that 
the process can be performed repeatedly, or in tandem with other measurements, throughout the 
normal life cycle of the cell. 
 In summary, the nanoinjector provides a fundamentally new mechanism for delivering a 
discrete, small number of molecules into cells without need for carrier solvent and with no 
apparent cell damage.  The unique capabilities of the nanoinjector can be further exploited in a 
number of ways.  Other biomolecules such as DNA and RNA, or synthetic structures such as 
polymers, dendrimers and nanoparticles can be delivered into cells in a similar fashion.  In 
conjunction with organelle-specific optical probes, the nanoinjector concept might be extended 
to the delivery of cargo to specific subcellular compartments.  In principle, cells such as bacteria 
that are too small for microinjection should be amenable to nanoinjection.  Notably, the 
8 
architecture of the nanoinjector allows the use of AFM to identify a target cell and position the 
nanoneedle, and is therefore not limited by the resolution of light microscopy.  
 
Materials and Methods: 
Materials.  All chemical reagents were of analytical grade, obtained from commercial suppliers 
and used without further purification.  The synthetic procedure of compound 1 and 2 is described 
in detail in supporting information published on the PNAS web site. 
Fabrication of MWNT-AFM tips  The fabrication of MWNT-AFM tips was carried out in an 
FEI Sirion XL 30 SEM, equipped with a home-made manipulator.  The procedure was described 
in detail in a previous publication (9). 
SEM and TEM characterization.  SEM images of MWNT-AFM tips were obtained on an FEI 
Sirion XL 30 SEM operated at 5 keV.  TEM images of unfunctionalized and functionalized 
MWNT-AFM tips were obtained on a JEOL 2011 microscope operating at an electron energy of 
100 keV.  A home-made holder was used for loading MWNT-AFM tips.  
Functionaliztion of MWNT-AFM tips.  QDot® 655 Streptavidin conjugates (1 μM solution, 
purchased from Invetrogen) were centrifuged at 5,000 × g, reserving the supernatant, prior to 
use.  The MWNT-AFM tips were incubated with linker 1 or 2 (1 μM, MeOH) at rt for 1 h, 
followed by washing 3 times with methanol and borate buffer (50 mM, pH = 8.3), respectively.  
The MWNT-AFM tips functionalized with 1 or 2 were then incubated with blocking buffer 
(borate buffer containing 1% BSA) for 30 min.  The blocked MWNT-AFM tips were then 
transferred to a solution of QDot® 655 Streptavidin conjugates (1:25 dilution) in borate buffer 
and incubated at rt for 30 min, followed by washing with borate buffer for 3 times.  The 
functionalized MWNT-AFM tips were then used directly for nanoinjection experiments or dried 
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under N2 for TEM characterization.  In a control experiment, the MWNT-AFM tips were 
incubated with blocking buffer for 30 min.  The blocked MWNT-AFM tips were then transferred 
to a solution of QDot® 655 Streptavidin conjugates (1:25 dilution) in borate buffer and incubated 
at rt for 30 min, followed by washing 3 times with borate buffer.  The MWNT-AFM tips were 
then dried under N2 for TEM characterization. 
Cell culture conditions.  HeLa cells were grown in DMEM supplemented with penicillin (100 
unit/mL), streptomycin (0.1 mg/mL), and 10% FCS and maintained in a 5% CO2, water-
saturated atmosphere at 37 oC. 
Cell Viability Studies.  The Hela cells after nanoinjection were studied using three cell viability 
assays: trypan blue exclusion assay, Calcein AM assay, and Annexin V-FITC/propidium iodide 
assay.  The experimental procedure is described in detail in supporting information published on 
the PNAS web site. 
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Figure Lengends: 
Fig. 1. Schematic of the nanoinjection procedure: A MWNT-AFM tip with cargo attached to the 
MWNT surface via a disulfide linker penetrates a cell membrane.  After disulfide reduction 
within the cell’s cytosol, the cargo is released and the nanoneedle is retracted. 
 
Fig. 2.  (A) SEM image of a MWNT-AFM tip. (B) TEM image of the tip region of (A). (C) 
TEM image of a MWNT-AFM tip coated with linker 1 and conjugated with QDot® Streptavidin. 
 
Fig. 3.  Functionalization of MWNT-AFM tips. (A) QDot® Streptavidin was attached to the 
MWNT surface though linker 1 containing a disulfide bond: (i) 1, MeOH; (ii) QDot® 
Streptavidin, borate buffer. (B) QDot® Streptavidin was attached to the MWNT surface though 
linker 2 containing no disulfide bond: (iii) 2, MeOH; (iv) QDot® Streptavidin, borate buffer. 
 
Fig. 4. Nanoinjection of QDot® Streptavidin conjugates into a target HeLa cell. (A) Fluorescence 
image of the cells before nanoinjection. (B) Combined bright-field and fluorescence image of the 
cells before nanoinjection. The inserted arrow indicates the target cell. The dark shape in the 
lower left corner is the AFM cantilever.  (C) Fluorescence image of the cells after the 
nanoinjection, showing fluorecent QDot® Streptavidin conjugates released inside the target cell. 
(D) Combined bright-field and fluorescence image of the cells after the nanoinjection.  The 
QDot® Streptavidin conjugates are shown in red.  The dark shape in the upper left corner is the 
retracted AFM cantilever.  (E) Combined bright-field and fluorescence image of another four 
examples of HeLa cells after nanoinjection of QDot® Streptavidin.  In all cases, fluorescence 
images were acquired with λex = 415 nm and data collection with a 655 nm filter.  Images are 70 
× 70 μm in (A)−(D) and 30 × 30 μm in (E). 
Fig. 1. 
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